BGB-3111-113
Completed
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
BeOne Study ID 
BGB-3111-113
ClinicalTrials.gov ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Study Documents
Study Protocol Statistical Analysis PlanStudy Overview
Sex:
All
Age: 18 Years / N/A